These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 37420273)

  • 1. Engineering considerations of iPSC-based personalized medicine.
    Park S; Gwon Y; Khan SA; Jang KJ; Kim J
    Biomater Res; 2023 Jul; 27(1):67. PubMed ID: 37420273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells in companion animals: how can we move the field forward?
    Barrachina L; Arshaghi TE; O'Brien A; Ivanovska A; Barry F
    Front Vet Sci; 2023; 10():1176772. PubMed ID: 37180067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
    Chehelgerdi M; Behdarvand Dehkordi F; Chehelgerdi M; Kabiri H; Salehian-Dehkordi H; Abdolvand M; Salmanizadeh S; Rashidi M; Niazmand A; Ahmadi S; Feizbakhshan S; Kabiri S; Vatandoost N; Ranjbarnejad T
    Mol Cancer; 2023 Nov; 22(1):189. PubMed ID: 38017433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking the Potential of Induced Pluripotent Stem Cells for Wound Healing: The Next Frontier of Regenerative Medicine.
    Dash BC; Korutla L; Vallabhajosyula P; Hsia HC
    Adv Wound Care (New Rochelle); 2022 Nov; 11(11):622-638. PubMed ID: 34155919
    [No Abstract]   [Full Text] [Related]  

  • 5. Unlocking the therapeutic potential: odyssey of induced pluripotent stem cells (iPSC) in precision cell therapies.
    Mohite P; Dave R; Budhar A; Munde S; Puri A; Ghosh SB; Alqahtani T; Shmrany HA; Kumer A; Dhara B
    Int J Surg; 2024 Jul; ():. PubMed ID: 38963728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
    Montgomery A; Wong A; Gabers N; Willerth SM
    Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.
    Pushp P; Nogueira DES; Rodrigues CAV; Ferreira FC; Cabral JMS; Gupta MK
    Stem Cell Rev Rep; 2021 Jun; 17(3):748-776. PubMed ID: 33098306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated generation of induced pluripotent stem cells in a low-cost device.
    Lin H; Li Q; Du Q; Wang O; Wang Z; Akert L; Carlson MA; Zhang C; Subramanian A; Zhang C; Lunning M; Li M; Lei Y
    Biomaterials; 2019 Jan; 189():23-36. PubMed ID: 30384126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles.
    Zhao S; Chen J; Wu L; Tao X; Yaqub N; Chang J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.
    Chun YS; Byun K; Lee B
    Anat Cell Biol; 2011 Dec; 44(4):245-55. PubMed ID: 22254153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering.
    Shukla AK; Gao G; Kim BS
    Micromachines (Basel); 2022 Jan; 13(2):. PubMed ID: 35208280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases.
    Chang EA; Jin SW; Nam MH; Kim SD
    J Korean Neurosurg Soc; 2019 Sep; 62(5):493-501. PubMed ID: 31392877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Considerations on Large-Scale Cultured Meat Production.
    Park S; Hong Y; Park S; Kim W; Gwon Y; Sharma H; Jang KJ; Kim J
    Tissue Eng Part B Rev; 2024 Aug; 30(4):423-435. PubMed ID: 38062728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
    Cong X; Zhang SM; Ellis MW; Luo J
    Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
    Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
    Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering.
    Liu Z; Zhou J; Wang H; Zhao M; Wang C
    Regen Med Res; 2013 Dec; 1(1):6. PubMed ID: 25984325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
    Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
    J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.